Summary:
«Recently, Bloomberg ran a story that set the health tech sphere abuzz. Citing insider knowledge, it claimed Apple had reached a major milestone in noninvasive blood glucose monitoring that could revolutionize diabetes treatment as we know it. But although this technology is buzzworthy, you won’t see it arrive on the Apple Watch — or any consumer-grade wearable — for several years to come.»
«Like other kinds of emerging health tech, noninvasive blood glucose monitoring has both technical and regulatory hurdles to clear. But even if Big Tech and researchers were to figure out a viable solution tomorrow, experts say the resulting tech likely won’t replace finger prick tests. As it turns out, that may not even be the most realistic or helpful use for the technology in the first place»
Article written by VICTORIA SONG
18|03|2023
Source:
The Verge